Kardiyak Kontraktilite Modülasyonu

Sümeyye Fatma Özer

doi:10.37609/akya.3125

Yazarlar

Sümeyye Fatma Özer

https://orcid.org/0000-0001-9053-621X

DOI: https://doi.org/10.37609/akya.3125.c12595

Özet

Referanslar

Abraham, W.T.; S.A. Smith "Devices in the management of advanced, chronic heart failure" Nat Rev Cardiol. (Feb 2013). 10 (2): 98–110

Giallauria, F.; et al. "Effects of cardiac contractility modulation by non-excitatory electrical stimulation on exercise capacity and quality of life: an individual patient's data meta-analysis of randomized controlled trials". Int J Cardiol. (Aug 2014).175 (2): 352–357.

Yu, C.M.; et al. "Impact of cardiac contractility modulation on left ventricular global and regional function and remodeling". JACC Cardiovasc Imaging. (Dec 2009). 2 (12): 1341–1349.

Kuschyk J, Kloppe A, Schmidt-Schweda S, Bonnemeier H, Rousso B, Roger S. Cardiac contractility modulation: a technical guide for device implantation. Rev Cardiovasc Med 2017;18:1–13.

Butter, C.; et al. "Enhanced inotropic state of the failing left ventricle by cardiac contractility modulation electrical signals is not associated with increased myocardial oxygen consumption". J Card Fail. (Mar 2007). 13 (2): 137–142.

Goliasch, G.; et al. "The effect of device-based cardiac contractility modulation therapy on myocardial efficiency and oxidative metabolism in patients with heart failure". Eur J Nucl Med Mol Imaging. (Mar 2012). 39 (3): 408–415.

Muller D, Remppis A, Schauerte P, Schmidt-Schweda S, Burkhoff D, Rousso B, Gutterman D, Senges J, Hindricks G, Kuck KH. Clinical effects of long-term cardiac contractility modulation (CCM) in subjects with heart failure caused by left ventricular systolic dysfunction. Clin Res Cardiol 2017;106:893–904.

Stix G, Borggrefe M, Wolpert C, Hindricks G, Kottkamp H, Bocker D, Wichter T, Mika Y, Ben-Haim S, Burkhoff D, Wolzt M, Schmidinger H. Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure. Eur Heart J 2004;25:650–655.

Borggrefe MM, Lawo T, Butter C, Schmidinger H, Lunati M, Pieske B, Misier AR, Curnis A, Bocker D, Remppis A, Kautzner J, Stuhlinger M, Leclerq C, Taborsky M, Frigerio M, Parides M, Burkhoff D, Hindricks G. Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. Eur Heart J 2008;29:1019–1028.

Kadish A, Nademanee K, Volosin K, Krueger S, Neelagaru S, Raval N, Obel O, Weiner S, Wish M, Carson P, Ellenbogen K, Bourge R, Parides M, Chiacchierini RP, Goldsmith R, Goldstein S, Mika Y, Burkhoff D, Abraham WT. A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. Am Heart J 2011;161:329–337.e1-2.

Abraham WT, Kuck KH, Goldsmith RL, Lindenfeld J, Reddy VY, Carson PE, Mann DL, Saville B, Parise H, Chan R, Wiegn P, Hastings JL, Kaplan AJ, Edelmann F, Luthje L, Kahwash R, Tomassoni GF, Gutterman DD, Stagg A, Burkhoff D, Hasenfuss G. A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation. JACC Heart Fail 2018;6:874–883.

Anker SD, Borggrefe M, Neuser H, Ohlow MA, Röger S, Goette A, Remppis BA, Kuck KH, Najarian KB, Gutterman DD, Rousso B, Burkhoff D, Hasenfuss G. Cardiac contractility modulation improves long-term survival and hospitalizations in heart failure with reduced ejection fraction. Eur J Heart Fail. 2019 Sep;21(9):1103-1113.

Pappone C, Rosanio S, Burkhoff D, Mika Y, Vicedomini G, Augello G, Shemer I, Prutchi D, Haddad W, Aviv R, Snir Y, Kronzon I, Alfieri O, Ben-Haim SA. Cardiac contractility modulation by electric currents applied during the refractory period in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2002;90:1307–1313.

Patent for CCM: Apparatus and method for controlling the delivery of contractility modulating non-excitatory signals to the heart (https://archive.today/20150308200716/http://patft.uspto.g ov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=/netahtml/PTO/search-bool.ht ml&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN/6360126)

Antoni, H.; R. Jacob; R. Kaufmann "Mechanical response of the frog and mammalian myocardium to changes in the action potential duration by constant current pulses". Pflügers Arch. (1969). 306 (1): 33–57.

Pappone, C.; et al. "Electrical modulation of cardiac contractility: clinical aspects in congestive heart failure". Heart Fail Rev. (Jan 2001). 6 (1): 55–60.

Burkhoff, D.; et al. "Electric currents applied during the refractory period can modulate cardiac contractility in vitro and in vivo". Heart Fail Rev. (Jan 2001). 6 (1): 27–34.

Stix, G.; et al. "Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure" (https://doi.org/10.1016%2Fj.ehj.2004.02.0 27). Eur Heart J. (Apr 2014). 25 (8): 650–655.

Brunckhorst CB, Shemer I, Mika Y, Ben-Haim SA, Burkhoff D. Cardiac contractility modulation by non-excitatory currents: studies in isolated cardiac muscle. Eur J Heart Fail 2006;8:7–15.

Burkhoff D, Shemer I, Felzen B, Shimizu J, Mika Y, Dickstein M, Prutchi D, Darvish N, Ben-Haim SA. Electric currents applied during the refractory period can modulate cardiac contractility in vitro and in vivo. Heart Fail Rev 2001;6:27–34.

Imai M, Rastogi S, Gupta RC, Mishra S, Sharov VG, Stanley WC, Mika Y, Rousso B, Burkhoff D, Ben-Haim S, Sabbah HN. Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure. J Am Coll Cardiol 2007;49:2120–2128.

Butter C, Rastogi S, Minden HH, Meyhofer J, Burkhoff D, Sabbah HN. Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure. J Am Coll Cardiol 2008;51:1784–1789.

Remppis A, Greten T, Schafer BW, Hunziker P, Erne P, Katus HA, Heizmann CW. Altered expression of the Ca2+-binding protein S100A1 in human cardiomyopathy. Biochim Biophys Acta 1996;1313:253–257.

Sengupta J, Kannampalli P, Belligoli A, Rousso B, Ben-Haim S, Gutterman D. Cardiac vagal afferent response in rats during cardiac contractility modulation (CCM) [abstract]. FASEB J 2015;29:651.6.

McMurray, J.J.V.; et al. "ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012" (https://doi.org/10.1093%2Feurheartj%2Fehs104). European Heart Journal. (2012). 33 (14): 1787–1847.

Kuck, K.-H.; et al. "New devices in heart failure: an European Heart Rhythm Association report: developed by the European Heart Rhythm Association; endorsed by the Heart Failure Association Europace. (Jan 2014). 16 (1): 109–128.

Burkhoff, D. (Dec 2011). "Does Contractility Modulation Have a Role in the Treatment of Heart Failure?". Curr Heart Fail Rep. (Dec 2011). 8 (4): 260–265.

Röger, S.; et al. "Long term impact of Cardiac Contractility Modulation on QRS Duration". J Electrocardiol. (Aug 2014). 47 (6): 936–40.

Abraham WT, Lindenfeld J, Reddy VY, Hasenfuss G, Kuck KH, Boscardin J, Gibbons R, Burkhoff D; FIX-HF-5C Investigators and Coordinators. A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with moderately reduced left ventricular ejection fraction and a narrow QRS duration: study rationale and design. J Card Fail 2015;21:16-23.

Linde C, et al. Cardiac contractility modulation therapy improves health status in patients with heart failure with preserved ejection fraction: a pilot study (CCM-HFpEF). Eur J Heart Fail. 2022. PMID: 35855646

Kadish,A.; et al. "A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure" (https://touroscholar.touro.edu/p resident_pubs/44). Am Heart J. (Feb 2011).161 (2): 329–337.

Burkhoff, D. "Does Contractility Modulation Have a Role in the Treatment of Heart Failure?". Curr Heart Fail Rep. (Dec 2011). 8 (4): 260–265.

Safety recommendations of the American HeartAssociation for patients with implantable cardioverter defibrillators (ICDs) (http://www.heart.org/HEARTORG/Conditions/Arrhythmia/P reventionTreatmentofArrhythmia/Implantable-Cardioverter-Defibrillator-ICD_UCM_448478_ Article.jsp)

Tips by the American HeartAssociuation "Living With Your Pacemaker" (http://www.heart.or g/HEARTORG/Conditions/Arrhythmia/PreventionTreatmentofArrhythmia/Living-With-Your-P acemaker_UCM_305290_Article.jsp

Dill, T. "Contraindications to magnetic resonance imaging" Heart. (Jul 2008).94 (7): 943–948.